v3.22.1

BALANCE SHEETS - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 1,679	$ 15,633
Sundry debtors and prepayments	0	0
Total current assets	1,679	15,633
TOTAL ASSETS	1,679	15,633
Current liabilities:
Accounts payable and accrued liabilities	124,526	123,999
Loans from related parties	376,250	376,250
Total current liabilities	500,776	500,249
Total liabilities	500,776	500,249
Stockholders' Equity (Deficit)
Preferred stock; $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding
Common stock, $0.0001 par value; 250,000,000 shares authorized; 77,350,003 shares issued and outstanding at March 31, 2022 and at December 31, 2021	7,735	7,735
Additional paid-in capital	352,681	352,681
Accumulated deficit	(859,513)	(845,032)
Total Stockholders' Equity (Deficit)	(499,097)	(484,616)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)	$ 1,679	$ 15,633

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Bio-En Holdings Corp. 10-Q